Adam Levy Sells 4,000 Shares of NexGel (NASDAQ:NXGL) Stock

NexGel, Inc. (NASDAQ:NXGL) CEO Adam Levy sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $2.52, for a total transaction of $10,080.00. Following the completion of the transaction, the chief executive officer owned 367,692 shares in the company, valued at $926,583.84. This represents a 1.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

NexGel Trading Up 3.8%

NASDAQ:NXGL traded up $0.09 during midday trading on Friday, reaching $2.48. 57,997 shares of the stock traded hands, compared to its average volume of 67,456. The stock has a market capitalization of $20.19 million, a P/E ratio of -6.20 and a beta of 0.57. The company has a debt-to-equity ratio of 0.16, a quick ratio of 0.98 and a current ratio of 1.74. The company has a fifty day moving average of $2.47 and a 200 day moving average of $2.46. NexGel, Inc. has a 12 month low of $2.10 and a 12 month high of $5.10.

NexGel (NASDAQ:NXGL) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The firm had revenue of $2.88 million during the quarter, compared to analysts’ expectations of $3.08 million. NexGel had a negative net margin of 25.02% and a negative return on equity of 49.37%.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of NexGel in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Institutional Trading of NexGel

Several institutional investors and hedge funds have recently bought and sold shares of NXGL. Flaharty Asset Management LLC purchased a new position in shares of NexGel during the 3rd quarter worth approximately $59,000. Malaga Cove Capital LLC bought a new stake in shares of NexGel during the second quarter valued at approximately $27,000. Evernest Financial Advisors LLC grew its stake in NexGel by 25.1% in the second quarter. Evernest Financial Advisors LLC now owns 281,000 shares of the company’s stock worth $725,000 after purchasing an additional 56,334 shares during the period. XTX Topco Ltd bought a new position in NexGel in the first quarter worth $30,000. Finally, Essex Investment Management Co. LLC purchased a new position in NexGel during the first quarter valued at $115,000. 2.21% of the stock is currently owned by hedge funds and other institutional investors.

NexGel Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.